Keyphrases
Treatment Outcome
100%
Prognostic Factors
100%
Lung Cancer Patients
100%
Small Cell Lung Cancer
100%
Extensive-stage
100%
Overall Survival
66%
Limited-stage
66%
Hazard Ratio
33%
Multivariable Model
33%
Treatment Patterns
33%
Performance Status
33%
Clinical Trials
16%
Israel
16%
Doublet
16%
Healthcare Organizations
16%
Incident Cases
16%
Rechallenge
16%
Median Survival
16%
Confounding Factors
16%
Large State
16%
State Mandates
16%
Topotecan
16%
Platinum Sensitivity
16%
Line of Therapy
16%
ECOG Performance Status
16%
Switching Treatment
16%
Ever Smokers
16%
Pattern Factor
16%
Systemic Anti-cancer Treatment
16%
Medicine and Dentistry
Prognostic Factor
100%
Small Cell Lung Cancer
100%
Overall Survival
80%
Hazard Ratio
40%
Clinical Trial
20%
Observational Study
20%
Cancer Therapy
20%
Topotecan
20%
Electrocorticography
20%
Pharmacology, Toxicology and Pharmaceutical Science
Small Cell Lung Cancer
100%
Overall Survival
80%
Clinical Trial
20%
Malignant Neoplasm
20%
Observational Study
20%
Topotecan
20%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Clinical Trial
25%
Anticancer
25%
Observational Study
25%
Electrocorticography
25%